Global Plasma Protein Therapeutics Market Size By Product (Human Serum Protein, Plasma-Derived Clotting Factor), By Application (Research Laboratories And Institutions, Hospitals), By Geographic Scope And Forecast

Plasma Protein Therapeutics Market Size And Forecast

Plasma Protein Therapeutics Market size was valued at USD 25.71 Billion in 2021 and is projected to reach USD 48.06 Billion by 2030, growing at a CAGR of 7.32% from 2023 to 2030.

The rising prevalence of autoimmune disorders, immune deficiency disorders, and bleeding disorders as well as the increasing adoption of plasma protein therapy in neurology and other therapeutic indications are expected to propel the market growth during the forecasted period. The Global Plasma Protein Therapeutics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Plasma Protein Therapeutics Market Definition

Think of plasma as the yellowish, liquid part of your blood. It's packed with proteins - hundreds of them! - doing all sorts of important jobs, like acting as antibodies to defend you from diseases and making sure your blood clots properly. But if your body doesn't have enough of a certain plasma protein, things can go wrong, leading to serious health problems. That's where plasma therapy comes in. These treatments, which include therapies made directly from plasma or lab-grown versions, are all about replacing those missing proteins so people can live healthier, more normal lives.

Deficiency can occur owing to an autoimmune disorder or it can be genetic. There are around 250 products that are derived from plasma. key players generally rely on Immunoglobulin and albumin. owing to advancements in plasma-fractionation techniques, and because of several innovative processes, human blood can be used to produce plasma-derived therapies. That might be used to treat an expanding list of debilitating, life-threatening, and chronic disorders.

Think of plasma proteins as helpful superheroes! Immunoglobulins come to the rescue for people struggling with immune deficiencies and autoimmune diseases. And for those with hemophilia A and B, or other bleeding issues, we have clotting-factor therapies ready to help. Then there's albumin, the go-to for folks experiencing shock, trauma, burns, and other emergencies in acute situations. In the world of blood clotting, or hemostasis, these plasma proteins are often used to replace missing elements when someone has a coagulation factor deficiency. This deficiency can be inherited, pop up due to an immune disorder, or even be a side effect of cancer treatment. Finally, fibrinogen acts as a replacement therapy when dealing with hemorrhagic diathesis in diseases like dysfibrinogenemia, afibrinogenemia, and hypofibrinogenemia. In short, plasma proteins are a vital part of helping people live healthier lives!

Global Plasma Protein Therapeutics Market Overview

We're seeing more and more autoimmune diseases, immune deficiencies, and bleeding disorders, and that's expected to really boost the growth of the market in the years to come. Plus, plasma therapy is being used more often in neurology and other areas, which is also a big factor. Let's not forget that the number of older adults is growing, and they're more likely to have neurological problems. On top of all that, pharmaceutical and biotech companies are putting a lot of money into research and development, which definitely helps the market. There's a lot of research happening in the plasma protein therapy area, and that's expected to lead to it being used in even more ways. And finally, because therapeutic protein drugs are being used to treat so many different things, we expect to see even more opportunities for this market in the future. It's a rapidly changing field.

The approval of some new plasma-derived therapies throughout the world will help to increase demand. Over the forecasted period, the aforementioned reasons are likely to boost the growth of the Plasma Protein Therapeutics Market. In addition, approval of plasma products across multiple indications, increasing R & D activities, and high demand for advanced therapeutic options are expected to fuel the market growth. Technological advancements, favorable reimbursement policies, and improved standard of living have led to increased life expectancy, contributing to a rise in the geriatric population.

Plasma-derived IG is a real workhorse, tackling all sorts of autoimmune and inflammatory diseases. But, the big reason we're seeing such a surge in demand for IG is the increasing use of high-dose treatments, especially for those tricky autoimmune neurologic disorders. And let's not forget that plasma protein therapies are also a lifeline for people battling rare diseases. Think about itImmunoglobulins step in to help folks with immune deficiencies and autoimmune conditions, clotting-factor therapies are crucial for those with hemophilia A and B and other bleeding issues, and albumin provides support to individuals experiencing shock, trauma, burns, and other critical situations in acute settings. All these factors are really what's fueling the progress and wider use of plasma protein therapeutics and their applications.

However, the major restrain for the market is imposed stringent restrictions and regulations regarding plasma therapy, particularly for the handling of plasma protein products. There is a lack of reimbursement policies, therefore, might affect the adoption of plasma therapy. Also, the required lead time between plasma collection and getting the product is long, it possesses challenges in front of the market. Furthermore, Increased awareness and treatment of immune deficiencies in developing countries have increased the global demand for immunoglobulin. This is a lucrative growth opportunity for market growth.

Global Plasma Protein Therapeutics MarketSegmentation Analysis

The Global Plasma Protein Therapeutics Market is Segmented on the basis of Product, Application, and Geography.

Plasma Protein Therapeutics Market, By Product

• Human Serum Protein
• Plasma-Derived Clotting Factor
• Immunoglobulin
• High Immunoglobulin

Based on Product, The market is segmented into Human Serum Protein, Plasma-Derived Clotting Factor, Immunoglobulin, and High Immunoglobulin. The Immunoglobulin segment held the major market share and is projected to grow at a significant CAGR during the forecasted period. This is owing to the rising use of immunoglobulin for primary as well as secondary immunodeficiency disorders in order to cure bacterial and viral infections.

Plasma Protein Therapeutics Market, By Application

• Research Laboratories And Institutions
• Hospitals
• Stand-Alone Blood Banks

Based on Application, The market is segmented into Research Laboratories And Institutions, Hospitals, and Stand-Alone Blood Banks. The Hospitals segment is expected to have a significant CAGR and is anticipated to hold a major market share in the forecast period. This is owing to the increasing adoption of plasma therapy in the hospital segment for the treatment of various disorders.

Plasma Protein Therapeutics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, The Global Plasma Protein Therapeutics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America will hold a significant share of the market, followed by Europe. The market is expected to be driven by factors such as the growing geriatric population, the presence of a large patient base, and well-developed infrastructure for storing and maintaining high-quality source plasma across the respective region.

Key Players

The “Global Plasma Protein Therapeutics Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Baxter, CSL Behring, Grifols Therapeutics, Octapharma, Abeona Therapeutics, ADMA Biologics, Amag Pharmaceuticals, Antares Pharma, BioDelivery Sciences, Bio Products Laboratory, Biota Pharmaceuticals, Biotest Pharmaceuticals, and China Biologic Products.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We'll dive into the market with both qualitative and quantitative methods, segmenting it by economic and non-economic stuff. You'll get market value data (in USD Billion!) for every segment and sub-segment. We'll point out which region and segment should grow the fastest and be the biggest. Plus, we'll analyze each region, looking at product/service use and the things affecting the market there. See who's on top with a competitive landscape, ranking major players and highlighting new service/product launches, partnerships, expansions, and acquisitions from the last five years. We also offer in-depth company profiles with overviews, insights, product benchmarking, and SWOT analysis for those key players. Get the current and future market outlook, covering growth opportunities, drivers, challenges, and restraints in both emerging and developed regions. We provide an in-depth analysis using Porter's five forces and a peek into the market's Value Chain. Finally, explore market dynamics and future growth opportunities. Oh, and you get 6 months of analyst support after the sale!

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.